|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004870 |
16-01-2020 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
PERTUZUMAB AND TRASTUZUMAB |
L01FY01 |
FR
|
I
|
|
|
|
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
OXALIPLATIN |
L01XA03 |
FR
|
I
|
|
FR/H/0284/002/ |
12-03-2015 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
CETUXIMAB |
L01XC06 |
FR
|
I
|
|
|
|
VALID
|
|
AMINOLEVULINIC ACID |
L01XD04 |
FR
|
I
|
23-02-2017 |
|
|
VALID
|
|
PADELIPORFIN |
L01XD07 |
FR
|
I
|
10-04-2018 |
EMEA/H/C/004182 |
15-11-2017 |
VALID
|
|
FEDRATINIB |
L01XE57 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
TRETINOIN |
L01XF01 |
FR
|
I
|
23-01-2019 |
FR/H/0106/001/II/030 |
22-10-2008 |
VALID
|
|
BORTEZOMIB |
L01XG01 |
FR
|
I
|
|
|
|
VALID
|
|
IXAZOMIB |
L01XG03 |
FR
|
I
|
18-08-2017 |
EMEA/H/C/003844 |
21-11-2016 |
VALID
|
|
PANOBINOSTAT |
L01XH03 |
FR
|
I
|
07-04-2016 |
EMEA/H/C/003725 |
28-08-2015 |
VALID
|
|
SONIDEGIB |
L01XJ02 |
FR
|
I
|
07-04-2016 |
EMEA/H/C/002839 |
14-08-2015 |
VALID
|
|
NIRAPARIB |
L01XK02 |
FR
|
I
|
10-04-2018 |
EMEA/H/C/004249 |
08-01-2018 |
VALID
|
|
RUCAPARIB |
L01XK03 |
FR
|
I
|
12-11-2018 |
EMEA/H/C/004272 |
23-08-2018 |
VALID
|
|
TALAZOPARIB |
L01XK04 |
FR
|
I
|
27-11-2019 |
EMEA/H/C/004674 |
19-06-2019 |
VALID
|
|
AXICABTAGENE CILOLEUCEL |
L01XL03 |
FR
|
I
|
|
EMEA/H/C/004480 |
09-02-2018 |
VALID
|
|
TISAGENLECLEUCEL |
L01XL04 |
FR
|
I
|
|
EMEA/H/C/004090 |
19-07-2018 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/004662 |
18-08-2021 |
VALID
|
|
PEGASPARGASE |
L01XX24 |
FR
|
I
|
|
|
|
VALID
|
|
ARSENIC TRIOXIDE |
L01XX27 |
FR
|
I
|
|
|
|
VALID
|
|
ANAGRELIDE |
L01XX35 |
FR
|
I
|
|
|
|
VALID
|
|
AFLIBERCEPT |
L01XX44 |
FR
|
I
|
|
|
|
VALID
|
|
VENETOCLAX |
L01XX52 |
FR
|
I
|
18-08-2017 |
EMEA/H/C/004106 |
05-12-2016 |
VALID
|
|
GLASDEGIB |
L01XX63 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004878 |
26-06-2020 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
ADAGRASIB |
L01XX77 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
IMETELSTAT |
L01XX80 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
CYTARABINE AND DAUNORUBICIN |
L01XY01 |
FR
|
I
|
12-11-2018 |
EMEA/H/C/004282 |
21-09-2018 |
VALID
|
|
MEDROXYPROGESTERONE |
L02AB02 |
FR
|
I
|
|
|
|
VALID
|
|
LEUPRORELIN |
L02AE02 |
FR
|
I
|
|
|
|
VALID
|
|
HISTRELIN |
L02AE05 |
FR
|
I
|
|
None |
|
VALID
|
|
TAMOXIFEN |
L02BA01 |
FR
|
I
|
|
|
|
VALID
|
|
FULVESTRANT |
L02BA03 |
FR
|
I
|
|
|
|
VALID
|
|
APALUTAMIDE |
L02BB05 |
FR
|
I
|
21-10-2019 |
EMEA/H/C/004452 |
14-01-2019 |
VALID
|
|
DAROLUTAMIDE |
L02BB06 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004790 |
27-03-2020 |
VALID
|
